Correlation Between Takeda Pharmaceutical and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Sangamo Therapeutics, you can compare the effects of market volatilities on Takeda Pharmaceutical and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Sangamo Therapeutics.
Diversification Opportunities for Takeda Pharmaceutical and Sangamo Therapeutics
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Takeda and Sangamo is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Sangamo Therapeutics
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 7.81 times less risky than Sangamo Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Sangamo Therapeutics on August 31, 2024 and sell it today you would earn a total of 102.00 from holding Sangamo Therapeutics or generate 79.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Takeda Pharmaceutical Co vs. Sangamo Therapeutics
Performance |
Timeline |
Takeda Pharmaceutical |
Sangamo Therapeutics |
Takeda Pharmaceutical and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Takeda Pharmaceutical and Sangamo Therapeutics
The main advantage of trading using opposite Takeda Pharmaceutical and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.Takeda Pharmaceutical vs. Bausch Health Companies | Takeda Pharmaceutical vs. Haleon plc | Takeda Pharmaceutical vs. Intracellular Th |
Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |